美国 · SEC FORM 4
ZIMMER BIOMET HOLDINGS, INC.
ZBH · NYSE · CIK 0001136869 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
4 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-11-09 · Jafry Syed A..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 9,745,945
- 上期报告
- 8,576,677
- 日均成交量
- 2,220,737
- 回补天数
- 4.4
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-11-09 | Jafry Syed A. | 买入 (P) | Common Stock | 2,135 | USD 104.75 | USD 223,641 | SEC 申报 ↗ |
| 2023-08-30 | Kolli Sreelakshmi | 买入 (P) | Common Stock | 1,000 | USD 120.37 | USD 120,370 | SEC 申报 ↗ |
| 2023-08-28 | BEGLEY CHRISTOPHER B | 买入 (P) | Common Stock | 1,000 | USD 117.11 | USD 117,110 | SEC 申报 ↗ |
| 2023-08-28 | HAGEMANN ROBERT | 买入 (P) | Common Stock | 2,000 | USD 116.48 | USD 232,960 | SEC 申报 ↗ |
| 2023-08-25 | MICHELSON MICHAEL W | 买入 (P) | Common Stock | 1,300 | USD 115.50 | USD 150,150 | SEC 申报 ↗ |
| 2023-08-25 | BERNARD BETSY J | 买入 (P) | Common Stock | 871 | USD 114.84 | USD 100,026 | SEC 申报 ↗ |
| 2023-08-23 | HIGGINS ARTHUR J | 买入 (P) | Common Stock | 1,000 | USD 115.61 | USD 115,615 | SEC 申报 ↗ |
| 2021-05-06 | HIGGINS ARTHUR J | 买入 (P) | Common Stock | 1,000 | USD 171.58 | USD 171,580 | SEC 申报 ↗ |
| 2020-05-13 | Hanson Bryan C | 买入 (P) | Common Stock | 1,000 | USD 113.00 | USD 113,000 | SEC 申报 ↗ |
Form 4 申报证据
74 transaction lines in the latest 365-day window; 295 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | 期权行权/转换 (M) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Campbell Gary Craig | 代扣税 (F) | Common Stock | 1,412 | USD 88.42 | USD 124,849 | SEC 申报 ↗ |
| 2026-09-11 | Thornal Kevin R | 卖出 (S) | Common Stock | 5,691 | USD 92.95 | USD 528,978 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | 期权行权/转换 (M) | Common Stock | 3,586 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-10-01 | Campbell Gary Craig | 代扣税 (F) | Common Stock | 1,412 | USD 88.42 | USD 124,849 | SEC 申报 ↗ |
| 2026-09-11 | Thornal Kevin R | 卖出 (S) | Common Stock | 5,691 | USD 92.95 | USD 528,978 | SEC 申报 ↗ |
| 2026-09-04 | Phipps Chad F | 卖出 (S) | Common Stock | 3,000 | USD 98.35 | USD 295,050 | SEC 申报 ↗ |
| 2026-08-01 | Thornal Kevin R | 期权行权/转换 (M) | Common Stock | 9,957 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-01 | Thornal Kevin R | 代扣税 (F) | Common Stock | 4,266 | USD 92.68 | USD 395,373 | SEC 申报 ↗ |
| 2026-05-29 | Yi Sang | 卖出 (S) | Common Stock | 5,000 | USD 82.64 | USD 413,216 | SEC 申报 ↗ |
| 2026-04-01 | Noor Jehanzeb | 期权行权/转换 (M) | Common Stock | 6,626 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Noor Jehanzeb | 代扣税 (F) | Common Stock | 1,677 | USD 90.67 | USD 152,054 | SEC 申报 ↗ |
| 2026-03-12 | Winkler Lori | 卖出 (S) | Common Stock | 2,650 | USD 94.66 | USD 250,849 | SEC 申报 ↗ |
| 2026-03-06 | Yi Sang | 期权行权/转换 (M) | Common Stock | 9,414 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Winkler Lori | 期权行权/转换 (M) | Common Stock | 5,634 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Winkler Lori | 代扣税 (F) | Common Stock | 2,178 | USD 92.54 | USD 201,552 | SEC 申报 ↗ |
| 2026-03-06 | VAN ZUILEN WILFRED | 期权行权/转换 (M) | Common Stock | 7,004 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | VAN ZUILEN WILFRED | 代扣税 (F) | Common Stock | 1,822 | USD 92.54 | USD 168,608 | SEC 申报 ↗ |
| 2026-03-06 | Upadhyay Suketu | 期权行权/转换 (M) | Common Stock | 14,776 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Upadhyay Suketu | 代扣税 (F) | Common Stock | 6,576 | USD 92.54 | USD 608,543 | SEC 申报 ↗ |
| 2026-03-06 | Tornos Ivan | 期权行权/转换 (M) | Common Stock | 34,704 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Tornos Ivan | 代扣税 (F) | Common Stock | 19,195 | USD 92.54 | USD 1,776,305 | SEC 申报 ↗ |
| 2026-03-06 | Stellato Paul A | 期权行权/转换 (M) | Common Stock | 1,970 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Stellato Paul A | 代扣税 (F) | Common Stock | 915 | USD 92.54 | USD 84,674 | SEC 申报 ↗ |
| 2026-03-06 | Phipps Chad F | 期权行权/转换 (M) | Common Stock | 6,786 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Phipps Chad F | 代扣税 (F) | Common Stock | 2,732 | USD 92.54 | USD 252,819 | SEC 申报 ↗ |
| 2026-02-25 | Yi Sang | 期权行权/转换 (M) | Common Stock | 2,785 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-25 | Winkler Lori | 期权行权/转换 (M) | Common Stock | 2,347 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-25 | Winkler Lori | 代扣税 (F) | Common Stock | 924 | USD 99.51 | USD 91,947 | SEC 申报 ↗ |
| 2026-02-25 | VAN ZUILEN WILFRED | 期权行权/转换 (M) | Common Stock | 3,182 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-25 | VAN ZUILEN WILFRED | 代扣税 (F) | Common Stock | 828 | USD 99.51 | USD 82,394 | SEC 申报 ↗ |
| 2026-02-25 | Upadhyay Suketu | 期权行权/转换 (M) | Common Stock | 6,364 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-25 | Upadhyay Suketu | 代扣税 (F) | Common Stock | 2,832 | USD 99.51 | USD 281,812 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ZBH |
| CIK | 0001136869 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 295 transaction lines from 2020-02-26 to 2026-10-01 10 P purchase lines · 29 S sale lines · 256 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.